Postprandial Regulation of Bone Perfusion in Healthy Individuals

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals - Nature Metabolism

GLP-1-boosting fibre approved as safe by European regulator, could be added to foods within a year

A novel form of fibre that stimulates the release of hunger-reducing hormones like GLP-1 (similar to drugs such as Wegovy and Ozempic) has b

GLP-1-boosting fibre approved as safe by European regulator, could be added to foods within a year

A novel form of fibre that stimulates the release of hunger-reducing hormones like GLP-1 (similar to drugs such as Wegovy and Ozempic) has b

GLP-1-boosting fibre approved as safe by European regulator, could be added to foods within a year

A novel form of fibre that stimulates the release of hunger-reducing hormones like GLP-1 (similar to drugs such as Wegovy and Ozempic) has b

Triple hormone drug retatrutide shows promise for diabetes and weight loss in Lancet trial

A new triple hormone drug called retatrutide, which mimics GLP-1, GIP, and glucagon, has shown promising results in a Lancet-published trial

Las semillas comestibles ganan protagonismo en la prevención de enfermedades crónicas

Can Continuous Glucose Monitoring (CGM) serve as a fuel gauge for athletes?

This article explores whether Continuous Glucose Monitoring (CGM) technology, now available to athletes, can serve as a reliable "fuel gauge

GLP-1 Receptor Agonists Linked to Small Risk of Smell and Taste Disturbances in Type 2 Diabetes

A study published in JAMA Otolaryngology-Head & Neck Surgery found that GLP-1 receptor agonists (RAs) used for type 2 diabetes are associate